Target intelligence / Profile preview

WNT1-inducible-signaling pathway protein 2 (WISP-2 (also known as CCN5))

Target
WISP-2 (also known as CCN5)
Molecular classification
Matricellular protein, Extracellular matrix-associated signaling protein, Member of the CCN family (cellular communication network factors)
01

Overview

WNT1-inducible-signaling pathway protein 2 is a matricellular signaling molecule encoded by the WISP2 gene in humans. It is also known as CCN5 and belongs to the six-member CCN family of extracellular matrix-associated proteins. Unlike other members of this family, WISP‑2 lacks a C-terminal cystine knot domain. The protein plays important roles in regulating cellular processes such as adhesion, migration, proliferation, and differentiation. Functionally, it acts as an inhibitor for vascular smooth muscle cells' proliferation and suppresses motility/invasiveness in some cancer cells—particularly breast carcinoma cells. Additionally, it has been shown to inhibit cardiac hypertrophy and fibrosis. WISP‑2/CCN5 is considered a potential therapeutic target due to its regulatory effects on tumor growth/metastasis and tissue remodeling; however, no approved drugs directly targeting this molecule are currently documented[1][2].

Other names
CCN5CT58CTGF-LWISP2cellular communication network factor 5Cop1HICP
02

Biological functions

Regulation of cell adhesionRegulation of cell migrationRegulation of cell proliferationInhibition of vascular smooth muscle and myometrial cell proliferationInhibition of breast carcinoma cell motility and invasiveness
03

Disease associations

Cancer (notably breast cancer)Cardiac hypertrophy and fibrosis
04

Safety considerations

No specific safety concerns or therapeutic challenges are well-documented in the current literature
05

Biomarkers

Potential biomarker for tumor progression or suppression in certain cancers (e.g., breast cancer)

Beyond the preview

Go deeper on WNT1-inducible-signaling pathway protein 2 (WISP-2 (also known as CCN5)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WNT1-inducible-signaling pathway protein 2 (WISP-2 (also known as CCN5)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call